臨床婦人科産科77巻3号

2023年04月発行

今月の臨床 乳腺―産婦人科医が知っておくべき必須知識

乳がんの治療と管理

初期治療―外科治療，化学療法・放射線療法

著者： 林田哲¹ 北川雄光¹

所属機関： ¹慶應義塾大学医学部一般・消化器外科

ページ範囲：P.347 - P.352

文献概要

●乳がんは初期治療の段階で全身病ととらえて治療を行うべきであり，手術・放射線治療といった局所に対する治療と並行して，全身に対する薬物療法が必須である．

●サブタイプごとにまったく異なるがん種と考え，使用する薬物療法を根本から変化させていく必要がある．

●乳がん治療では根治性の追求は当然であるが，乳房の整容性にも配慮を行う必要があるため，時には乳房再建術を検討しつつこれを実現する必要がある．

参考文献

1）Hartkopf AD, et al : Disseminated tumor cells from the bone marrow of patients with nonmetastatic primary breast cancer are predictive of locoregional relapse. Ann Oncol 26 : 1155-1160, 2015

2）Lucci A, et al : Circulating tumour cells in non-metastatic breast cancer : a prospective study. Lancet Oncol 13 : 688-695, 2012

3）Perou CM, et al : Molecular portraits of human breast tumours. Nature 406 : 747-752, 2000

4）Sparano JA, et al : Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer. N Engl J Med 379 : 111-121, 2018

5）Johnston SRD, et al : Abemaciclib combined with endocrine therapy for the adjuvant treatment of HR+, HER2-, node-positive, high-risk, early breast cancer（monarchE）. J Clin Oncol 38 : 3987-3998, 2020

6）Gianni L, et al : Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer（NeoSphere） : a randomised multicentre, open-label, phase 2 trial. Lancet Oncol 13 : 25-32, 2012

7）von Minckwitz G, et al : Trastuzumab emtansine for residual invasive HER2-Positive breast cancer. N Engl J Med 380 : 617-628, 2019

8）Tolaney SM, et al : Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer. N Engl J Med 372 : 134-141, 2015

9）von Minckwitz G, et al : Adjuvant pertuzumab and trastuzumab in early HER2-positive breast cancer. N Engl J Med 377 : 122-131, 2017

10）Schmid P, et al : Pembrolizumab for early triple-negative breast cancer. N Engl J Med 382 : 810-821, 2020

11）Tutt ANJ, et al : Adjuvant olaparib for patients with BRCA1- or BRCA2-mutated breast cancer. N Engl J Med 384 : 2394-2405, 2021

12）Veronesi U, et al : Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347 : 1227-1232, 2002

13）Clarke M, et al : Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival : an overview of the randomised trials. Lancet 366 : 2087-2106, 2005

14）van Dongen JA, et al : Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer : EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer. Eur J Cancer 28A : 801-805, 1992

15）Giuliano AE, et al : Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis : a randomized clinical trial. JAMA 305 : 569-575, 2011

16）Donker M, et al : Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer（EORTC 10981-22023 AMAROS） : a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol 15 : 1303-1310, 2014